Monsanto Roundup Lawsuit

Friday, April 30, 2010

AstraZeneca's PR Machine Caught With Their Pants Down!



Image: theworldofhowey.files.wordpress.com



Well, well, well.

It seems AstraZeneca have been caught with their pants down again.

Not long after licking their wounds re the Seroquel debacle, it now appears they have been busted by... wait for it... a blogger.

Deary me pharma. If you are going to monitor those that write about you then make sure you don't make your database publicly available.

1000 shiny stars to Stan who writes the “Is Something Not Quite Right With Stan,” blog.

Jim Edwards of BNet writes:


The database was prepared by v-Fluence, a pr firm employed by AZ. The agency’s chief, Jay Byrne, published a blog item this morning explaining why drug companies monitor web coverage. Big Food conspiracy theorists can look here for more information on Byrne, a former director of public affairs for Monsanto.


It seems they are now accusing Stan of 'hacking' into their database. Hmmmm. About as believable as the safety and efficacy of Seroquel!

Stepheny, who writes the Soulful Sepulcher blog has a rant about AstraZeneca and Jay Byrne here. It seems that both AstraZeneca and Jay Byrne have been all over her blog today.


Reminds me of a special report the MHRA had commissioned to basically see how their image was on the Internet. I'll give them their dues though, they actually went public with it and didn't put it on a dodgy database that could be opened with the blink of an eye.

This one goes out to V-Fluence, the PR company that are paid to track what bloggers are writing about the pharmaceutical industry.

Thanks for the balls-up - you have made me laugh for the first time today.



Stan, take a bow sir. I salute you.

Stan's blog can be found HERE, his leading story is 'v-Fluence responds to hacking by blogger - v-fluence ties to BIG Pharma'




Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
Post a Comment